Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Ferroprotoporphyrin
2. Haem
3. Heme
4. Heme B
5. Protoheme Ix
1. Heme
2. Heme B
3. 14875-96-8
4. Ferroprotoporphyrin
5. Ferroheme
6. Reduced Hematin
7. Haem
8. Protoheme Ix
9. Iron Protoporphyrin Ix
10. Hematin
11. Protohaem
12. Ferrous Protoheme
13. Iron Protoporphyrin
14. Ferrous Protoheme Ix
15. Ferroprotoporphyrin Ix
16. 42vzt0u6yr
17. Iron(ii) Protoporphyrin Ix
18. Normosang
19. 3-[18-(2-carboxyethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethylporphyrin-21,24-diid-2-yl]propanoic Acid;iron(2+)
20. Protoheme Ix (van)
21. Ferroheme (van)
22. Heme (van)
23. Hem
24. Unii-42vzt0u6yr
25. Nsc 16669
26. Globifer
27. Nsc 267100
28. Human Hemin
29. Heme Iron
30. Heme [mi]
31. Gtpl4349
32. Mfcd00870215
33. Ferrate(2-), (7,12-diethenyl-3,8,13,17-tetramethyl-21h,23h-porphine-2,18-dipropanoato(4-)-n21,n22,n23,n24)-, Dihydrogen, (sp-4-2)-
34. 85758-ep2270016a1
35. 85758-ep2270505a1
36. 85758-ep2305243a1
37. 85758-ep2305825a1
38. Q620084
39. Iron, (dihydrogen 3,7,12,17-tetramethyl-8,13-divinyl-2,18-porphinedipropionato(2-))-
40. [7,12-diethenyl-3,8,13,17-tetramethyl-21h,23h-porphine-2,18-dipropanoato(4-)-n^21,n^22,n^23,n^24]-ferrate(2-)dihydrogen
41. 3-[18-(2-carboxyethyl)-3,8,13,17-tetramethyl-7,12-divinyl-porphyrin-21,23-diid-2-yl]propanoic Acid
42. Ferrate(2-), (7,12-diethenyl-3,8,13,17-tetramethyl-21h,23h-porphine-2,18-dipropanoato(4-)-kappan21,kappan22,kappan23,kappan24)-, Dihydrogen, (sp-4-2)-
43. Ferrate(2-), (7,12-diethenyl-3,8,13,17-tetramethyl-21h,23h-porphine-2,18-dipropanoato(4-)-kappan21,kappan22,kappan23,kappan24)-, Hydrogen (1:2), (sp-4-2)-
44. Ferrous 3-[(1z,4z,9z,15z)-18-(2-carboxyethyl)-3,7,12,17-tetramethyl-8,13-divinyl-21,23-dihydroporphyrin-2-yl]propanoic Acid
| Molecular Weight | 616.5 g/mol |
|---|---|
| Molecular Formula | C34H32FeN4O4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 8 |
| Exact Mass | 616.177291 g/mol |
| Monoisotopic Mass | 616.177291 g/mol |
| Topological Polar Surface Area | 102 Ų |
| Heavy Atom Count | 43 |
| Formal Charge | 0 |
| Complexity | 1010 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Digital Content
NEWS #PharmaBuzz
Market Place
ABOUT THIS PAGE
58
PharmaCompass offers a list of Heme API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Heme manufacturer or Heme supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Heme manufacturer or Heme supplier.
PharmaCompass also assists you with knowing the Heme API Price utilized in the formulation of products. Heme API Price is not always fixed or binding as the Heme Price is obtained through a variety of data sources. The Heme Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Heme manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Heme, including repackagers and relabelers. The FDA regulates Heme manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Heme API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Heme manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Heme supplier is an individual or a company that provides Heme active pharmaceutical ingredient (API) or Heme finished formulations upon request. The Heme suppliers may include Heme API manufacturers, exporters, distributors and traders.
click here to find a list of Heme suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Heme Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Heme GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Heme GMP manufacturer or Heme GMP API supplier for your needs.
A Heme CoA (Certificate of Analysis) is a formal document that attests to Heme's compliance with Heme specifications and serves as a tool for batch-level quality control.
Heme CoA mostly includes findings from lab analyses of a specific batch. For each Heme CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Heme may be tested according to a variety of international standards, such as European Pharmacopoeia (Heme EP), Heme JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Heme USP).
